about
Structural Analysis of the 14-3-3ζ/Chibby Interaction Involved in Wnt/β-Catenin SignalingS100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis RestrictionWnt Signaling in Renal Cell CarcinomaAnti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalSclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and ChallengesWnt Signaling in Cancer Stem Cell BiologyAdvances in targeted and immunobased therapies for colorectal cancer in the genomic eraSignal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their CrosstalksNew therapeutic strategies for BRAF mutant colorectal cancersTherapies targeting cancer stem cells: Current trends and future challengesDevelopment of anticancer agents targeting the Wnt/β-catenin signalingDiametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunologySignaling in Fibrosis: TGF-β, WNT, and YAP/TAZ ConvergeTargeting the Wnt pathways for therapiesWnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesisThe Mediator complex: a central integrator of transcriptionProgress and renewal in gustation: new insights into taste bud developmentT memory stem cells and HIV: a long-term relationshipMonitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells.A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus InfectionWnt signaling networks in autism spectrum disorder and intellectual disabilityRegulation of Wnt/β-catenin signaling by herpesvirusesRole of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature reviewNewly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression DataEstimation of Prognostic Marker Genes by Public Microarray Data in Patients with Ovarian Serous CystadenocarcinomaHypoxia-regulated human periodontal ligament cells via Wnt/β-catenin signaling pathway.Mitochondrial uncoupler exerts a synthetic lethal effect against β-catenin mutant tumor cellsSmall molecule p300/catenin antagonist enhances hematopoietic recovery after radiation.Wnt-β Catenin Signaling Pathway: A Major Player in the Injury Induced Fibrosis and Dysfunction of the External Anal Sphincter.PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.Emergence of TNIK inhibitors in cancer therapeutics.Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction.Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC.CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.Updating the Wnt pathways.The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target.Moving upstream in the war on WNTs.Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen.
P2860
Q21131783-534A3130-50C3-4920-997F-2E0C24032122Q26743403-E9102557-626D-4319-9BE5-BA53277C9E7FQ26744312-B0501308-3ACC-4EB8-825C-517B564F12C5Q26744536-1871CB7C-1092-4222-AD78-1D01D874D54DQ26744599-F8ED8CFD-2A79-4B28-B608-A8D8941582F6Q26746101-A1E2DD76-4B17-42E1-8CD3-500A4F01A4EAQ26751344-6A9035A3-C694-43FE-A30C-BFE9156EABA1Q26752554-F734CBEA-69D3-4699-B376-C6CABFD609F7Q26772277-B76D0098-6AD2-477B-93AD-C854FC46D2BCQ26777880-51316280-FE3A-40E4-96C2-927995CD3A3AQ26781898-C8AC3B95-B1E1-4E06-8D63-5028062801A7Q26782139-230CEBC6-0A42-4F44-9389-5B8C32FB67BFQ26782820-31E26B30-6B8F-45B7-9B79-55A01C3E25BEQ26821978-E4A9589B-EAF1-48E2-8129-24279565E139Q26825046-F48B7A3C-5D4B-46FB-90E9-ECDD2EF7192CQ26849595-A8893C3D-466E-49E2-8F9E-C1ECECB956F3Q27009513-53E81C4B-BCD2-4400-82EF-D7FFF713A6A4Q27023930-89C81376-C22A-452D-8242-5357426E68B4Q27311697-6863163F-9626-49E6-B69F-0E68556EAA2FQ27468917-D5051D1E-124C-4D85-9370-7EE25D6BED97Q28074740-1F4975C2-D4C3-4189-B22C-795557A9B212Q28079414-EA6E0990-43EB-4955-B77C-D02EFAE4CFD7Q28086989-DF8C7659-0CEA-45A1-BC67-47D9E5CCF5B3Q31030029-090077DD-DF7E-4B8E-BA5E-1923C7F02491Q31096918-6A9E9830-07C1-412D-A73C-96ABE742C166Q33606103-627B9E1E-45A3-4E3B-B790-6A384D1FEC6CQ33607603-6F85E203-CE88-437C-8D03-B2B798488BC7Q33653273-5876710F-F78C-47F4-9A87-0133FD51C95FQ33681070-8612B032-DF9A-407B-8A20-C769F9769AF5Q33689649-38C75AB1-E0FD-44B4-812F-B4FB1E75D930Q33737058-1A2BF86F-1623-406B-83C2-40370DFFF8A2Q33738834-16B40B71-607F-48DC-8C59-7CF3791817C0Q33761925-238E6A9F-8BAA-48D3-A94B-E0EB9FC90666Q33827178-08BAC872-81D2-49BF-A182-13C88F5F6A90Q33926141-D4AEE26F-ED3F-466B-AA2B-761C5F2B2D99Q34360489-60C4F2FA-CD56-46A9-B5BE-671F54EC4944Q34670501-5C5BC0BD-7678-4D88-A23B-FD2C01AE9978Q35183964-AA39AEBA-5EDE-4837-AC64-BD5714E6341AQ35505126-14C19782-86F1-4C0C-A1CA-DED0C409B271Q35560868-8553C011-72FF-4615-9DD4-180CFC804A9E
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Can we safely target the WNT pathway?
@ast
Can we safely target the WNT pathway?
@en
type
label
Can we safely target the WNT pathway?
@ast
Can we safely target the WNT pathway?
@en
prefLabel
Can we safely target the WNT pathway?
@ast
Can we safely target the WNT pathway?
@en
P2860
P356
P1476
Can we safely target the WNT pathway?
@en
P2093
Michael Kahn
P2860
P2888
P304
P356
10.1038/NRD4233
P577
2014-07-01T00:00:00Z